Roche enters into agreement to acquire LumiraDx Point of Care technology combining multiple diagnostic modalities on single platform
Basel: Roche has announced the entry into a definitive agreement to acquire select parts of the LumiraDx group related to LumiraDx’s innovative Point of Care technology. Following closing of the transaction, which is expected by mid-2024, the acquired entities will be fully integrated into Roche Diagnostics. “The addition of the LumiraDx technology to our diagnostics portfolio […]